Ming Wu
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
Papers in
-
- Nanoplatforms for cancer theranostics 66
-
- Advanced Nanomaterials in Catalysis 15
- Luminescence and Fluorescent Materials 11
- Co-authors
- Xiaolong Liu (76 shared papers)Jingfeng Liu (40 shared papers)Da Zhang (37 shared papers)Yongyi Zeng (24 shared papers)Lingjie Wu (10 shared papers)Zuwu Wei (24 shared papers)Shengyong Yang (3 shared papers)Yueshan Li (3 shared papers)
- Journals
- ACS Applied Materials & Interfaces (10 papers)Journal of Materials Chemistry B (8 papers)Biomaterials Science (6 papers)Advanced Science (5 papers)Advanced Healthcare Materials (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ming Wu
103 papers receiving 5.1k citations
Ming Wu's Hit Papers
Peers
Comparison fields: 5 of 139
- Biomaterials 1.1k
- Biomedical Engineering 2.8k
- Materials Chemistry 1.3k
- Pulmonary and Respiratory Medicine 698
- Molecular Biology 1.6k
Countries citing papers authored by Ming Wu
This map shows the geographic impact of Ming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Wu more than expected).
Fields of papers citing papers by Ming Wu
This network shows the impact of papers produced by Ming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Wu. The network helps show where Ming Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Small molecules in targeted cancer therapy: advances, challenges, and future perspectives Hit paper breakdown → | 2021 | 1138 |
| 2 | 2015 | 333 | |
| 3 | 2019 | 147 | |
| 4 | 2014 | 144 | |
| 5 | 2015 | 139 | |
| 6 | 2018 | 84 | |
| 7 | 2016 | 81 | |
| 8 | 2020 | 81 | |
| 9 | 2018 | 79 | |
| 10 | 2009 | 79 | |
| 11 | 2015 | 78 | |
| 12 | 2020 | 78 | |
| 13 | 2021 | 77 | |
| 14 | 1991 | 73 | |
| 15 | 2018 | 72 | |
| 16 | 2014 | 72 | |
| 17 | 2019 | 72 | |
| 18 | 2019 | 70 | |
| 19 | 2018 | 70 | |
| 20 | 2018 | 67 |
About Ming Wu
Ming Wu is a scholar working on Biomedical Engineering, Materials Chemistry, Molecular Biology, Biomaterials and Oncology, having authored 103 papers that have together received 5.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (66 papers), Nanoparticle-Based Drug Delivery (24 papers), Advanced Nanomaterials in Catalysis (15 papers), Immunotherapy and Immune Responses (14 papers), Photodynamic Therapy Research Studies (13 papers), Luminescence and Fluorescent Materials (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Gold and Silver Nanoparticles Synthesis and Applications (9 papers). The work is most often cited by research in Biomaterials (1.1k citations), Biomedical Engineering (2.8k citations), Materials Chemistry (1.3k citations), Pulmonary and Respiratory Medicine (698 citations) and Molecular Biology (1.6k citations). Ming Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaolong Liu, Jingfeng Liu, Da Zhang, Yongyi Zeng, Lingjie Wu, Zuwu Wei, Shengyong Yang, Yueshan Li, Chenyu Tian and Wei Yang. Their work appears in journals such as ACS Applied Materials & Interfaces, Journal of Materials Chemistry B, Biomaterials Science, Advanced Science and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.